CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
Jan 06, 2020
SHANGHAI,?Jan 6, 2020?/PRNewswire/?--?CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced appointment of?Yong Fan, MD, as Senior Vice President, Global Regulatory Affairs. Dr. Fan, will be responsible for CARsgen global regulatory strategy, leading U.S. and?China?regulatory affairs team, working closely with clinical, medical and process development team, striving to achieve CARsgen global strategic objectives for immunotherapies.